跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
R-191
首页
药物
R-191
R-191
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Chimeric RSV, immunogenic compositions, and methods of use
US 11235050 B2
申请人: UNIV EMORY
优先权: 2015
CN
US
3 件公开
Piperidine derivatives useful as modulators of chemokine receptor activity
US 7265227 B2
申请人: ASTRAZENECA AB
优先权: 2001
US
2 件公开
Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
US 7122682 B2
申请人: UCB SA
优先权: 2001
US
2 件公开
Modified release pharmaceutical formulation
US 2005171083 A1
申请人: ASTRAZENECA AB
优先权: 2002
US
2 件公开
Isoxazoline derivatives as anti-depressants
US 7169786 B2
申请人: ANDRES-GIL JOSE IGNACIO
优先权: 2001
US
Fused heterocyclic compounds
US 2006135530 A1
申请人: OI SATORU
优先权: 2002
US
3-Substituted-4-pyrimidone derivatives
US 2007142409 A1
申请人: SANOFI AVENTIS OF PARIS FRANCE
优先权: 2002
US
Pyrimidine compounds and pests controlling composition containing the same
US 2006199800 A1
申请人: MIZUNO HAJIME
优先权: 2003
US
Use of hydroxyoleic acid and related compounds as functional food additives
US 2007099995 A1
申请人: ESCRIBA RUIZ PABLO V
优先权: 2003
US
Alkylammonium salts of omepazole and esomeprazole
US 2005182099 A1
申请人: DAHLSTROM MIKAEL
优先权: 2004
US
第 1 / 2 页
上一页
下一页
药物
反馈